🟢 Immunitybio is trading 5.2% up today, rebounding from recent weakness without a clear catalyst

Immunitybio is trading at $7.19 (5.2% up) in pre-market, rebounding from recent weakness following a strong after-hours move on July 29.

• The move appears to be largely technical and sentiment-driven as the stock gains momentum following the prior session’s recovery.
• There are currently no fresh company-specific headlines, earnings reports, FDA updates, or major analyst actions tied directly to this pre-market rise.